Slow Sodium

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Slow Sodium

Quick Facts

Property Description
Active Ingredient Sodium Chloride
Form Oral, Controlled-Release Tablet
Pharmacological Class Electrolyte Replenisher
Common Use Management of Hyponatremia (low sodium)
Origin Manufactured Formulation of a Natural Mineral

What Type of Supplement is Slow Sodium?

Slow Sodium is an oral, controlled-release tablet formulated with sodium chloride, and is an Electrolyte Replenisher. This specialized supplement plays a role in maintaining crucial fluid balance, which is vital for nerve and muscle function.

The differentiating feature of Slow Sodium is its sustained-release mechanism. Unlike standard, immediate-release supplements, its unique formulation is designed to release the sodium content gradually over several hours in the digestive tract. This controlled delivery method aims to provide a smoother, more regulated mineral supply, a characteristic often associated with electrolyte management.


Is Slow Sodium Natural or Synthetic?

While the base component, sodium chloride, is a naturally occurring essential inorganic salt critical for biological processes, the Slow Sodium product itself is a manufactured (synthetic) formulation.

This means the tablet's specialized coating and inner matrix are complex, engineered structures. The formulation is specifically designed to control the dissolution rate of the natural mineral, ensuring steady absorption that minimizes abrupt changes in the body’s electrolyte balance.


What is the General Therapeutic Purpose of Slow Sodium?

The general therapeutic purpose of Slow Sodium is to address and manage hyponatremia (low sodium levels). Its controlled-release nature makes it suited for individuals requiring prolonged, gradual correction of chronic or mild sodium deficiencies.

A typical use scenario involves providing steady support when a patient’s body is consistently losing sodium. This gentle, predictable replenishment is the main therapeutic advantage of selecting the Slow Sodium formulation over immediate-release options.

What side effects are possible with Slow Sodium?

Slow Sodium: Possible Side Effects and Safety Information

Adverse Reaction Profile

Official regulatory documents indicate that no side effects have been reported at the recommended dosage of Slow Sodium. However, risks are associated with excessive intake, individual patient conditions, and the nature of the prolonged-release formulation.

Serious and Clinically Significant Risks:

  • Hypernatraemia (Excessive Sodium): Overdose or administration without adequate water intake can lead to dangerously high blood sodium levels. Symptoms of hypernatraemia, a serious condition, include restlessness, dizziness, headache, delirium, rapid heartbeat (tachycardia), hypertension, and, in severe cases, respiratory arrest.
  • Gastrointestinal Obstruction: The prolonged-release tablet matrix is eliminated intact. There is a risk of intestinal obstruction in patients with pre-existing conditions that cause narrowing of the intestines, such as Crohn's disease, diverticulitis, or stricture formation.
  • Hypersensitivity: Allergic reactions to the active substance (sodium chloride) or excipients are possible.

Safety Restrictions and Contraindications

Slow Sodium is contraindicated in patients with known hypersensitivity and in any situation where salt retention is undesirable. This includes conditions such as oedema (fluid retention), heart disease/failure, cardiac decompensation, primary or secondary aldosteronism, or when a patient is receiving therapy intended to produce salt and water loss (e.g., certain diuretics).

Special Patient Populations:

  • Elderly and Children: Caution is advised, as both populations have a reduced capacity for renal sodium excretion, which increases the risk of toxic reactions. Dosage must be individually adjusted for children.
  • Pregnancy and Lactation: The medicine is not expected to have an adverse effect on fertility, pregnancy, or lactation when used at therapeutic doses.

Monitoring and Warnings

Administration of this medication requires adequate water supplementation to avoid the risk of hypernatraemia. The patient's underlying conditions, particularly hypertension or chronic renal failure, may necessitate closer monitoring due to potential impairment of antihypertensive drug efficacy.

Overdose and Emergency Response

The official regulatory documents specify that an overdose of Slow Sodium, resulting in hypernatremia (excess sodium), is classified as a potentially severe event. The documented overdose manifestations are linked to the toxic effects of high sodium concentration and subsequent fluid and solute overload. Clinical signs may include central nervous system effects such as confusion, restlessness, somnolence, and muscular twitching, alongside cardiovascular signs like tachycardia and hypertension.

Overdose Manifestations Severe Outcomes Documented
Confusion, restlessness, somnolence Seizures and cerebral edema
Tachycardia, hypertension, peripheral edema Pulmonary edema, respiratory failure, and death

When an overdose is suspected, emergency medical attention must be sought immediately, and the product administration must be discontinued at once. Officially described supportive treatment requires the continuous monitoring of the patient's fluid balance, serum electrolyte concentrations, and acid-base status. For acute oral ingestion, procedural steps such as gastric lavage are documented. Patients with severe renal impairment or congestive heart failure are noted to have an increased risk for toxic reactions related to fluid or solute overload. No specific pharmacological antidote is mentioned in the official prescribing information.

Therapeutic Uses of Slow Sodium

Quick Facts

  • Therapeutic Domain: Electrolyte replenishment
  • Primary Use: Management of sodium chloride deficiency
  • Secondary Use: Prevention of sodium chloride deficiency
  • Additional Use: May be employed for the control of muscle cramps associated with haemodialysis

Slow Sodium is utilized in clinical practice for the management and prophylaxis of conditions characterized by a deficiency of sodium chloride in the body. The goal of this medication is to help restore and maintain appropriate sodium balance, which is vital for the proper function of nerve and muscle cells.

It is specifically indicated for use in managing sodium loss and can be administered for the treatment of severe salt depletion. Additionally, it may be employed to address muscle cramps that can occur during routine maintenance haemodialysis, a process where sodium balance can be impacted.

Eligibility and Restrictions for Use

Slow Sodium is a prolonged-release sodium chloride supplement used for individuals with a deficiency of sodium chloride. Official regulatory documents define clear rules for its eligibility and populations who must not use it.

Populations Allowed

  • Adults: Indicated for the treatment and prevention of sodium chloride deficiency, including the control of muscle cramps during maintenance haemodialysis.
  • Children and Adolescents: Use is permitted, but the dosage must be adjusted according to the child's individual needs.
  • Older Adults: No special dosage adjustment is generally indicated.

Populations Who Must Not Use (Contraindications)

The medicine is strictly contraindicated and must not be used by individuals with:

  • Hypersensitivity or allergy to sodium chloride or any other ingredient in the tablet.
  • Any clinical state where salt retention is undesirable, which includes oedema (fluid retention), heart disease or cardiac decompensation (heart failure), and aldosteronism (excessive aldosterone hormone production).
  • Patients who are currently receiving therapy specifically intended to produce salt and water loss (e.g., certain diuretics).

Restrictions and Special Considerations

  • Intestinal Conditions: Use is not recommended in patients with Crohn's disease or other intestinal conditions where strictures or diverticula may form, due to the risk of obstruction from the tablet's intact matrix.
  • Water Balance: Adequate water supplementation is required when taking this medicine to prevent high sodium levels in the blood (hypernatraemia).
  • Pregnancy/Lactation: Use is generally considered to be without expected adverse effects at therapeutic doses.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The information regarding interactions for Slow Sodium (sodium chloride prolonged-release tablets) is strictly based on official government regulatory documents.

As an electrolyte replenisher, the product's documented interaction profile focuses on its impact on overall sodium and fluid balance, rather than metabolic enzyme pathways.


Documented Interaction Patterns

The official labeling identifies a risk of pharmacodynamic antagonism of efficacy when co-administered with certain blood pressure medications.

Interaction Type Interacting Agents
Efficacy Impairment Antihypertensive Agents

The specific interacting medicines noted in regulatory documents include common diuretics such as furosemide, bumetanide, and metolazone. The administration of sodium chloride may lead to a tendency to impair the intended therapeutic action of these antihypertensive drugs.


Population-Specific Notes and Restrictions

Constraint Type Details
Population-Specific Risk The interaction risk is specifically highlighted for hypertensive patients who also have chronic renal failure.
Timing Requirements No mandatory timing separation rules are documented in the official labeling.
Formal Contraindications No specific medicinal product combination is formally classified as a contraindicated combination based on drug-drug interaction mechanisms.

Regulatory documents contain no documented pharmacokinetic interactions (such as CYP-mediated) or interactions with food, alcohol, or herbal products.

Mechanism of Action

How Slow Sodium Works

Osmotic and Fluid Dynamics

The fundamental mechanism involves the active ingredient, the sodium ion ( Na^+), which acts as an essential substrate to modulate plasma osmolality and extracellular fluid distribution. The mechanism directly increases the concentration of the primary extracellular cation, generating an osmotic force that influences the pressure gradient governing water movement across cell membranes.

Cellular Electrochemical Gradient

Once absorbed, Na^+ replenishment affects the electrochemical gradient that powers the Na^+/ K^+-ATPase pump . This cellular process re-establishes the resting membrane potential necessary for the proper function of voltage-gated sodium channels, leading to the initiation of action potentials in nerve and muscle cells.

Mechanistic Rate Control

The specialized controlled-release formulation introduces a critical kinetic control to the overall mechanism. The matrix ensures the Na^+ substrate is delivered to the bloodstream gradually over several hours, ensuring the osmotic concentration increases slowly. This rate control is a required mechanistic constraint on the osmotic process to mitigate a swift osmotic shift across the blood-brain barrier.

Dosage and Administration Information

How to Use Slow Sodium

Slow Sodium (sodium chloride prolonged-release tablets) is designed to provide a controlled release of sodium. The following points describe the administration procedure for this formulation.


Administration and Dosing Scope

The medicine is taken via the oral route only. The dosage is individualized and determined by a healthcare professional based on the specific condition being managed:

Regimen Standard Dose (Adults)
Prophylaxis (Prevention) 4 to 8 tablets per day
Treatment (Severe Depletion) Up to a maximum of 20 tablets per day
Haemodialysis (Cramps) 10 to 16 tablets per dialysed day

For elderly patients, no specific dosage adjustment is required. Dosage for children and adolescents is determined by a physician to match individual needs.


Administration Technique

To preserve the prolonged-release mechanism, the tablets are swallowed whole.

  • Do not chew, crush, or break the prolonged-release tablets. Altering the tablet structure can lead to the rapid and uncontrolled release of sodium.
  • The tablets are taken with an adequate volume of water, typically approximately 70 mL per tablet, to facilitate passage and absorption.

This administration technique is intended to ensure the controlled, slow release of sodium as provided by the medicine's formulation.

Recent Clinical Evidence

️ Evidence for Use in Chronic Sodium Chloride Deficiency

Research has explored the use of controlled-release sodium chloride in individuals with chronic salt loss. Early clinical investigations examined the preparation in the context of preventing and addressing low sodium levels by monitoring changes in serum sodium concentration and electrolyte balance in adults with ongoing sodium loss. Research highlights changes measured during the short-term study periods.

The existing evidence base is limited by the absence of recent, large-scale, controlled clinical trials (RCTs) specifically designed to compare this formula against modern sodium replacement therapies. Results apply only to the populations studied in the original trials.


Studies Addressing Muscle Cramps in Haemodialysis

The use of oral sodium preparations was evaluated in studies that monitored outcomes related to physical discomfort, such as muscle cramps associated with maintenance haemodialysis. These studies monitored patient-reported outcomes focusing on the frequency and intensity of cramps following the preparation's use.

The evidence quality varies, drawing mainly from older, small-sample trials. Comparative evidence is lacking for certain groups, and data for long-term outcomes specifically tied to the controlled-release formula remain limited.


Research on the Controlled-Release Formulation and Tolerance

Pilot studies and comparative investigations examined the specialized, controlled-release design. Research monitored outcomes linked to inflammatory states, focusing on whether the slow delivery mechanism was associated with gastrointestinal irritation compared to immediate-release sodium chloride supplements.

Findings indicated that the controlled-release tablet was observed in some studies to have different acute tolerability patterns. This research is narrow in focus, primarily evaluating physical performance; limited information exists for long-term gastrointestinal health outcomes.


Evidence Gaps and Areas of Research Uncertainty

The research does not determine whether an individual will respond similarly to the group patterns reported. Significant limitations include the reliance on foundational research, modest sample sizes, and a lack of comparative evidence against current treatment strategies. More comprehensive research exploring long-term maintenance is still needed.

Key Studies & References

  1. Summary of Product Characteristics (SPC) for Sodium Chloride Controlled-Release Tablets
  2. Systematic Review of Controlled-Release Sodium Chloride for Hyponatremia Management
  3. Authoritative Clinical Guideline on Management of Hyponatremia and Salt-Losing Conditions
  4. Clinical Trials Database for Sodium Chloride Preparations (ICTRP)

Frequently Asked Questions (FAQ)

Common questions about Slow Sodium (FAQ)


Q: Why is it called 'Slow Sodium'?

A: The name refers to the specialized prolonged-release formulation of the tablet. This unique design is intended to release the sodium content gradually over a period of several hours within the digestive tract, as described in the official product information.


Q: What is the scientific name for the main ingredient in Slow Sodium?

A: The active ingredient in this medication is chemically known as sodium chloride. This essential substance is recognized as an electrolyte replenisher, and its concentration is regulated by the prolonged-release tablet structure.


Q: Are there any foods or drinks to avoid while using Slow Sodium?

A: Official documentation indicates that there are no documented interactions with standard food, alcohol, or herbal products. However, it is always important to maintain the required water intake specified for administration to ensure safety.


Q: Do I need to take Slow Sodium with food?

A: There is no official requirement to take the tablets with food. Regulatory guidelines mandate that the tablets must be swallowed whole with an adequate volume of water, which is typically approximately 70 mL per tablet.


Q: Is it necessary to drink extra water when taking Slow Sodium?

A: Adequate water supplementation is required when taking this product to help prevent the risk of developing dangerously high blood sodium levels, a condition called hypernatraemia. The required amount is approximately 70 mL of water per tablet. If there are concerns about fluid intake beyond the required amount, official information describes the need to consult with a healthcare professional.


Q: Can Slow Sodium cause stomach issues or nausea?

A: Official documents state that no side effects have been reported with this product at the recommended dosage. However, nausea is listed as one of the signs and symptoms that may occur if excessive intake leads to high blood sodium levels (hypernatraemia). Any discomfort experienced should be discussed with a medical practitioner.


Q: Why do some people say they feel thirsty after taking Slow Sodium?

A: Official documentation lists increased thirst as one of the signs and symptoms that may occur if excessive intake or inadequate water use leads to high blood sodium levels (hypernatraemia). Hypernatraemia is a serious condition.


Q: Are there any mental side effects linked to Slow Sodium, like dizziness?

A: Mental or neurological symptoms such as restlessness, delirium (confusion), dizziness, and headache are noted as possible signs that may occur with excessive intake of the product, which can result in high blood sodium levels.


Q: Does Slow Sodium affect my blood pressure?

A: Official labeling highlights that the use of this product may affect the intended action of blood pressure-lowering medications in some patients. This risk is specifically noted for hypertensive patients who also have chronic renal (kidney) failure.


Q: Can I take Slow Sodium if I am already on diuretics (water pills)?

A: The product is not recommended for use if you are receiving therapy specifically intended to produce salt and water loss, such as certain diuretics. Furthermore, it may affect the intended action of some anti-hypertensive diuretics. These restrictions are detailed in the official safety documents.


Q: Are there long-term risks associated with using Slow Sodium?

A: Potential serious acute risks include hypernatraemia (excessive sodium) from misuse and the risk of intestinal obstruction. The risk of obstruction is specifically noted for individuals with pre-existing intestinal conditions like strictures or diverticula, as the tablet matrix is eliminated intact.


Q: If I am lactose intolerant, is there lactose in Slow Sodium?

A: The official list of non-active ingredients (excipients) for the prolonged-release tablet does not include lactose. The formulation uses other components, such as cetostearyl alcohol, gelatin, and talc, to create the specialized delivery system.


Q: What should I do if I accidentally take two tablets at once?

A: If more than the prescribed amount is taken, official patient information advises contacting your doctor or the nearest casualty department (emergency room) immediately. Patients are advised to take the tablet container with them for clarity regarding the exact product taken.


Q: Can Slow Sodium affect my ability to drive or operate machinery?

A: Official product information states that this medicinal product is not expected to have any or negligible influence on the ability to drive or use machines. However, symptoms associated with high sodium levels, if they occur, could potentially impair mental abilities.


Q: What is the shelf life or expiry of Slow Sodium tablets?

A: The documented shelf life for the tablets is five years from the date of manufacture. The product should not be used after the expiry date shown on the label and is intended to be stored according to official instructions to maintain its integrity.


Q: Are there any specific patient groups where Slow Sodium is studied more?

A: Research has focused specifically on its use in individuals with chronic salt loss. Studies have also examined its use in patients undergoing maintenance haemodialysis for the control of muscle cramps, representing specific populations where the product has been evaluated.


Q: Why is the research on Slow Sodium described as limited?

A: The evidence base is noted as limited due to reliance on older, foundational research, modest sample sizes, and a current lack of recent large-scale clinical trials. Specifically, there is limited comparative evidence against modern sodium replacement strategies.


Q: Why is Slow Sodium sometimes suggested for people with certain neurological issues?

A: The main ingredient, the sodium ion, plays a necessary physiological role in nerve function. It is essential for establishing the electrochemical gradient needed to initiate electrical signals (action potentials) in nerve and muscle cells. This physiological role provides a context for its therapeutic use.

How should Slow Sodium be stored and disposed of?

Slow Sodium (Sodium Chloride Extended-Release Tablets) must be stored at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F). Permitted temperature excursions range from 15 C to 30 C.

The tablets must be protected from moisture and kept in the original container, which should be tightly closed. It is required to keep this medicine out of the reach of children.

Disposal of unused or expired tablets should preferentially be through a medicine take-back program. If one is unavailable, the product may be mixed with an undesirable substance and placed in a sealed bag for household trash. The regulatory guidance states that the medicine should not be flushed down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Slow Sodium found in:

A-Z Index: